24 Aug 2026, 09:55
Presentations—
CYCCYCLOPHARM LIMITED
Announcement history available from 1 August 2025
Fromto
24 Aug 2026, 08:09
Financial ResultsMS
24 Aug 2026, 08:09
Financial ResultsMS
29 July 2026, 08:31
Company UpdateMS
28 July 2026, 08:50
Presentations—
15 July 2026, 08:29
Company UpdateMS
6 July 2026, 15:05
Securities Administration—
2 July 2026, 10:11
Periodic ReportsMS
25 June 2026, 17:19
Substantial Holders—
8 May 2026, 14:32
Director Interests—
8 May 2026, 14:31
Director Interests—
8 May 2026, 14:28
Meetings & Governance—
8 May 2026, 10:14
Presentations—
8 May 2026, 10:12
Company Administration—
8 May 2026, 10:11
Company Administration—
4 May 2026, 09:51
Meetings & Governance—
4 May 2026, 09:47
Director Interests—
22 Apr 2026, 09:03
Substantial Holders—
20 Apr 2026, 13:09
Securities Administration—
20 Apr 2026, 12:57
Securities Administration—
20 Apr 2026, 10:42
Meetings & Governance—
10 Apr 2026, 11:18
Meetings & Governance—
7 Apr 2026, 10:26
Director Interests—
7 Apr 2026, 10:24
Company Administration—
31 Mar 2026, 08:42
Company UpdateMS
27 Mar 2026, 16:56
Company Administration—
27 Mar 2026, 16:53
Financial Results—
24 Mar 2026, 08:28
Company UpdateMS
23 Mar 2026, 09:16
Company UpdateMS
12 Mar 2026, 13:19
Director Interests—
12 Mar 2026, 13:19
Director Interests—
12 Mar 2026, 13:18
Director Interests—
12 Mar 2026, 13:17
Director Interests—
12 Mar 2026, 13:15
Director Interests—
12 Mar 2026, 10:10
Securities Administration—
10 Mar 2026, 11:21
Meetings & Governance—
9 Mar 2026, 11:52
ASX Query—
9 Mar 2026, 11:35
Capital Raising—
25 Feb 2026, 17:20
Securities Administration—
25 Feb 2026, 17:12
Financial ResultsMS
25 Feb 2026, 17:06
Company Administration—
19 Feb 2026, 12:31
Company UpdateMS
18 Feb 2026, 12:32
Company UpdateMS
13 Feb 2026, 16:28
Substantial Holders—
12 Feb 2026, 09:10
Capital Raising—
11 Feb 2026, 09:18
Capital Raising—
11 Feb 2026, 09:14
Securities Administration—
4 Feb 2026, 09:41
Securities Administration—
4 Feb 2026, 09:41
PresentationsMS
4 Feb 2026, 09:40
Capital RaisingMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 24 Aug 2026, 09:55 | Cyclopharm 1H 2026 Results Webinar | Presentations | — | 03014, 14014 | |
| 24 Aug 2026, 08:09 | CYC 1H2026 Results Summary | Financial Results | MS | 03004, 03026 | |
| 24 Aug 2026, 08:09 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 29 July 2026, 08:31 | New US Lung Imaging Guidelines Name Technegas as Preferred A | Company Update | MS | 11001 | |
| 28 July 2026, 08:50 | ausbiz TV Presentation | Presentations | — | 03026 | |
| 15 July 2026, 08:29 | Immediate 11-Site Technegas Rollout at University Hospitals | Company Update | MS | 11001 | |
| 6 July 2026, 15:05 | Notification of cessation of securities - CYC | Securities Administration | — | 06027 | |
| 2 July 2026, 10:11 | CYC First-Half 2026 Update | Periodic Reports | MS | 03014 | |
| 25 June 2026, 17:19 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 8 May 2026, 14:32 | Final Director's Interest Notice - KB | Director Interests | — | 02010 | |
| 8 May 2026, 14:31 | Final Director's Interest Notice - DH | Director Interests | — | 02010 | |
| 8 May 2026, 14:28 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 8 May 2026, 10:14 | CYC 2026 AGM Presentation | Presentations | — | 02006, 03026, 12001, 15002 | |
| 8 May 2026, 10:12 | Managing Director's Address to Shareholders | Company Administration | — | 12001, 15002 | |
| 8 May 2026, 10:11 | Chair's Address to Shareholders | Company Administration | — | 12001, 12017, 15002 | |
| 4 May 2026, 09:51 | Appointment of Non-Executive Director and Incoming Chair | Meetings & Governance | — | 08006, 12001, 12017 | |
| 4 May 2026, 09:47 | Initial Director's Interest Notice - DC | Director Interests | — | 02008 | |
| 22 Apr 2026, 09:03 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 20 Apr 2026, 13:09 | Cleansing Notice | Securities Administration | — | 06018 | |
| 20 Apr 2026, 12:57 | Application for quotation of securities - CYC | Securities Administration | — | 06020 | |
| 20 Apr 2026, 10:42 | AGM - Supplementary Disclosure | Meetings & Governance | — | 06009, 08006 | |
| 10 Apr 2026, 11:18 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 7 Apr 2026, 10:26 | Final Director's Interest Notice - JW | Director Interests | — | 02010 | |
| 7 Apr 2026, 10:24 | Resignation of Non-Executive Director John Wigglesworth | Company Administration | — | 12001 | |
| 31 Mar 2026, 08:42 | USA Technegas Expansion Update | Company Update | MS | 11001 | |
| 27 Mar 2026, 16:56 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 27 Mar 2026, 16:53 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 24 Mar 2026, 08:28 | CYC Secures Multi-Site Agreement with Northwestern Medicine | Company Update | MS | 11001 | |
| 23 Mar 2026, 09:16 | CYC Signs Enterprise Agreement with UPHS | Company Update | MS | 11001 | |
| 12 Mar 2026, 13:19 | Change of Director's Interest Notice - KB | Director Interests | — | 02009 | |
| 12 Mar 2026, 13:19 | Change of Director's Interest Notice - JW | Director Interests | — | 02009 | |
| 12 Mar 2026, 13:18 | Change of Director's Interest Notice - DA | Director Interests | — | 02009 | |
| 12 Mar 2026, 13:17 | Change of Director's Interest Notice - JM | Director Interests | — | 02009 | |
| 12 Mar 2026, 13:15 | Change of Director's Interest Notice - DH | Director Interests | — | 02009 | |
| 12 Mar 2026, 10:10 | Application for quotation of securities - CYC | Securities Administration | — | 06020 | |
| 10 Mar 2026, 11:21 | Date of Annual General Meeting | Meetings & Governance | — | 08006, 12008 | |
| 9 Mar 2026, 11:52 | Response to ASX Aware Letter | ASX Query | — | 17003 | |
| 9 Mar 2026, 11:35 | Results of CYC Share Purchase Plan | Capital Raising | — | 06017 | |
| 25 Feb 2026, 17:20 | Update - Proposed issue of securities - CYC | Securities Administration | — | 06013 | |
| 25 Feb 2026, 17:12 | Preliminary Final Report | Financial Results | MS | 03003 | |
| 25 Feb 2026, 17:06 | Chairman David Heaney to Retire at 2026 AGM | Company Administration | — | 12017 | |
| 19 Feb 2026, 12:31 | Technegas US Footprint Expanding Across Four Regions | Company Update | MS | 11001 | |
| 18 Feb 2026, 12:32 | Technegas Approved at the US National Institutes of Health | Company Update | MS | 11001 | |
| 13 Feb 2026, 16:28 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 12 Feb 2026, 09:10 | Share Purchase Plan Offer Booklet | Capital Raising | — | 06017, 16002 | |
| 11 Feb 2026, 09:18 | Cleansing Notice | Capital Raising | — | 06003, 06018 | |
| 11 Feb 2026, 09:14 | Application for quotation of securities - CYC | Securities Administration | — | 06020 | |
| 4 Feb 2026, 09:41 | Proposed issue of securities - CYC | Securities Administration | — | 06013 | |
| 4 Feb 2026, 09:41 | Cyclopharm Capital Raising Investor Presentation | Presentations | MS | 03026 | |
| 4 Feb 2026, 09:40 | Cyclopharm Successfully Completes A$14 million Placement | Capital Raising | MS | 06003, 06017, 09014 |
1–50 of 66
1 / 2